IL10 and Arthritis: In fact, work from our group has demonstrated that neutrophil-derived EVs, which display anti-inflammatory activity, can be loaded with therapeutic cargo including anti-TNF-α as well as IL-10 and targeted to arthritic joints using cartilage specific antibodies to improve experimental arthritis (Figure 2) [151,152,153].